Altria(MO)

Search documents
轻工制造行业周报:海外烟草龙头2025H1财报梳理:新型烟草增速向好-20250804
Guoxin Securities· 2025-08-04 09:48
Investment Rating - The report maintains an "Outperform" rating for the light industry sector [6][10]. Core Insights - Recent financial reports from major overseas tobacco companies for H1 2025 show overall stable performance, with new tobacco products continuing to drive growth. British American Tobacco, Philip Morris International, and Japan Tobacco have all raised their annual forecasts [18]. Summary by Relevant Sections British American Tobacco (BAT) - For H1 2025, BAT reported revenues of £12.069 billion, a decrease of 2.2% year-on-year, with new tobacco products accounting for 13.7% of total revenue [2][19]. - The revenue from heated tobacco products was £440 million, showing a slight increase of 0.8%, while the revenue from new oral tobacco products surged by 38.1% to £470 million [20][21]. Philip Morris International (PMI) - PMI's Q2 2025 net revenue reached $10.14 billion, reflecting a year-on-year increase of 7.1%, with smoke-free tobacco products making up 41.6% of total revenue [3][28]. - The global shipment of heated tobacco units was 38.8 billion, up 9.2% year-on-year, with IQOS market share in Japan increasing to 31.7% [29]. Japan Tobacco - Japan Tobacco reported Q2 2025 revenues of ¥907.6 billion, a 9.4% increase year-on-year, with heated tobacco product shipments rising by 31.2% [4][38]. - The company has adjusted its annual revenue growth forecast to 8.4% and operating profit growth to 14.6% [38]. Altria - Altria's Q2 2025 revenue was $6.1 billion, down 1.7% year-on-year, with oral tobacco product revenue increasing by 5.9% [5][12]. Market Overview - The light industry sector experienced a relative return of +0.16% last week, despite a decline of 1.59% in the overall sector [6][9]. - Furniture retail sales in June increased by 28.7% year-on-year, while building materials sales saw a decline of 8.9% [6][12]. Investment Recommendations - The report recommends focusing on leading companies in the home furnishing sector, such as Oppein Home, Sophia, and Kuka Home, as well as in the paper and packaging sectors, highlighting Sun Paper and Yutong Technology as key investment opportunities [9][16].
Altria Has a Big Dividend Yield, but Is It Sustainable?
The Motley Fool· 2025-08-04 01:05
Core Viewpoint - Altria Group is experiencing rising earnings due to price increases, but is facing significant declines in cigarette volumes, raising concerns about the sustainability of its dividend payouts [1][10]. Financial Performance - In Q2, Altria reported a 1.7% decline in overall revenue net of excise taxes to $5.29 billion, while adjusted EPS increased by 8.3% to $1.44, surpassing analyst expectations [3]. - The oral products segment, which includes on! nicotine pouches, saw a 6% revenue increase to $728 million, with shipment volumes rising 26.5% to 52.1 million cans [4]. - The cigarette business experienced a 10.2% decline in overall shipment volumes, with Marlboro brand shipments down 11.4% and other premium brands down 13% [5]. Dividend Analysis - Altria currently pays a quarterly dividend of $1.02, totaling an annual rate of $4.08, with operating cash flow and free cash flow at $2.9 billion for the first half of the year, while dividends paid amounted to $3.5 billion [8]. - Cash flows are not covering the dividend payout for the first half of the year, which raises concerns, although the company covered $6.8 billion in dividends last year with $8.6 billion in free cash flow [9]. - The company ended the quarter with a debt-to-EBITDA leverage of 2 times, indicating that the dividend appears sustainable in the near term [9]. Market Position and Valuation - Altria's pricing power is strong, but the continuous decline in cigarette volumes poses a risk to future revenue [10]. - The company trades at a forward P/E ratio of 11.5 based on 2025 analyst consensus, which is lower than its former unit, Philip Morris International [11]. - Despite being a solid dividend play, the stock is at a six-year high, and the ongoing volume declines in its core business suggest caution for potential investors [11].
Altria: The Highest Yielding Tobacco Stock
Seeking Alpha· 2025-08-02 13:44
Group 1 - Altria is recognized for providing high dividend yields, making it a prominent choice for dividend-seeking investors [1] - The company has a long history of delivering substantial returns to investors through dividends [1] - The focus on stable and increasing dividends is seen as foundational for achieving high risk-adjusted long-term returns [1] Group 2 - The analysis emphasizes the importance of in-depth company evaluation and the formulation of compelling investment arguments [1] - Engaging with the investment community through platforms like Seeking Alpha enhances knowledge and investment strategies [1]
Altria (MO) Q2 EPS Jumps 8%
The Motley Fool· 2025-08-01 01:19
Core Insights - Altria Group reported Q2 2025 results with adjusted earnings and revenue exceeding analyst expectations, driven by price increases and growth in oral tobacco products [1][2] - Adjusted diluted EPS was $1.44, surpassing the estimate of $1.39, and revenue reached $6.10 billion, despite a 1.7% decline year-over-year [1][2] Financial Performance - Adjusted diluted EPS (Non-GAAP) was $1.44, up 8.3% year-over-year, compared to $1.33 in Q2 2024 [2] - Revenue (GAAP) was $6.10 billion, down 1.7% from $6.21 billion in Q2 2024, with smokeable products revenue at $5.36 billion, a 2.5% decline [2][5] - Oral tobacco products revenue increased by 5.9% to $753 million, driven by a 26.5% rise in on! nicotine pouch shipments [2][6] Business Overview and Strategy - Altria is a leading U.S. tobacco company known for Marlboro cigarettes and a range of smoke-free products, focusing on transitioning adult smokers to non-combustible products [3][4] - The company is investing in nicotine pouches and has made acquisitions like NJOY e-vapor to enhance its product offerings [4] Segment Performance - The smokeable products segment faced challenges, with a 10.2% drop in U.S. cigarette shipment volumes, leading to a 2.5% revenue decline [5] - Despite volume declines, the adjusted margin for smokeable products improved by 2.9 percentage points to 64.5% due to price increases and cost control [5] - Oral tobacco products showed growth, but total shipment volume declined by 1.0%, indicating challenges in traditional brands [6] Regulatory and Competitive Environment - The company is navigating a highly regulated environment and is focused on compliance and monitoring the impact of tariffs on its supply chain [8] - NJOY ACE, Altria's main e-vapor device, is currently off the U.S. market due to patent litigation, affecting its momentum in the e-vapor category [7] Capital Deployment and Shareholder Returns - In the first half of 2025, Altria returned $3.5 billion to shareholders through dividends and $600 million through share repurchases [9] - The company has $400 million remaining in its buyback authorization and maintains a focus on operational efficiency [9] Future Guidance - Altria raised its full-year 2025 adjusted diluted EPS guidance to a range of $5.35 to $5.45, projecting up to 5.0% growth [11] - The company continues its consistent dividend program and share repurchases, while monitoring developments in smoke-free product launches and regulatory outlooks [12]
Altria Among 6 Dividend Kings To Announce Annual Payout Increases In August
Seeking Alpha· 2025-07-31 23:40
Core Insights - The article emphasizes the effectiveness of investing in dividend growth stocks and reinvesting dividends as a strategy for long-term wealth growth [1] Group 1: Investment Strategy - The individual investor has explored various investment styles over 25 years, concluding that dividend growth stocks are a reliable method for wealth accumulation [1] - The investor has experience with a diverse range of investment vehicles, including stocks, options, ETFs, treasury notes, and mutual funds [1] - The blog, HarvestingDividends.com, focuses on providing information about S&P Dividend Aristocrats and other dividend growth stocks [1]
Will Strong Pricing Power Offset Altria's Volume Declines in 2025?
ZACKS· 2025-07-31 16:11
Core Insights - Altria Group, Inc. is focusing on pricing strength to manage ongoing declines in cigarette volumes, with a 10.2% year-over-year drop in domestic cigarette shipment volumes in Q2 2025, while adjusted operating income for smokeable products increased by 4.2% due to a 10% rise in net price realization [1][8] Pricing Strategy - The ability to raise prices despite volume declines is a key feature of Altria's business model, with Marlboro expanding its premium segment share to 59.5%, which supports above-inflation price increases and enhances the company's pricing power [2] Market Dynamics - The cigarette industry is facing sustained pressure, with the discount retail share rising to 31.2%, indicating financial strain among adult tobacco consumers. Altria is responding by selectively expanding its Basic discount brand into approximately 30,000 targeted stores to retain value-oriented smokers [3] Earnings Outlook - Altria's management has raised its adjusted earnings per share guidance for 2025 to a range of $5.35 to $5.45, reflecting confidence in its premium pricing strategy to offset industry volume declines [4][8] Competitor Analysis - Philip Morris International Inc. reported a 6.8% organic net revenue growth in Q2 2025, with pricing contributing significantly to this growth, while Turning Point Brands focuses on brand strength and market positioning rather than aggressive pricing [5][6] Stock Performance - Altria's shares have increased by 5.7% over the past month, contrasting with a 1% decline in the industry [7] Valuation Metrics - Altria is trading at a forward price-to-earnings ratio of 11.26X, which is lower than the industry average of 14.66X [9] Earnings Estimates - The Zacks Consensus Estimate indicates year-over-year earnings growth of 4.9% for 2025 and 3.1% for 2026, with current estimates for Q3 2025 at $1.43 and for the full year at $5.37 [10][11]
Why Altria (MO) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-07-31 14:51
Company Overview - Altria Group is adapting to changing industry dynamics, focusing on expanding beyond traditional cigarettes into the smokeless category due to rising health consciousness and government regulations [12] - Revenues from the oral product category are steadily increasing, driven by the growing popularity of reduced-risk products [12] Zacks Rank and Style Scores - Altria has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [13] - The company has a Momentum Style Score of B, with shares increasing by 3.9% over the past four weeks [13] - Two analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.02 to $5.37 per share [13] - Altria has an average earnings surprise of +3.3%, suggesting a positive outlook [13] Investment Considerations - With a strong Zacks Rank and high Momentum and VGM Style Scores, Altria is recommended for investors' consideration [14]
Dividend Harvesting Portfolio Week 230: $23,000 Allocated, $2,428.39 In Projected Dividends
Seeking Alpha· 2025-07-31 12:45
I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking Alpha Analyst's Disclosure:I/we have a beneficial long position in the shares of QDVO, AGNC, ...
Want Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks.
The Motley Fool· 2025-07-31 09:51
Group 1: Altria Group - Altria Group's shares have increased by approximately 15% over the past 12 months despite a decline in cigarette volumes, with Marlboro shipment volume dropping by 11.4% year over year in Q2 [4][5] - The company has experienced a slight revenue decline of 0.4% year over year, but margin expansion has led to a 4.4% increase in operating income [5] - Altria's oral tobacco product sales rose by 6% year over year, and the company may benefit from increased regulatory oversight of unauthorized nicotine products [6] - The stock offers a 6.7% yield, with a history of consistent dividend increases, marking the 59th payout raise in 55 years [7] Group 2: Healthpeak Properties - Healthpeak Properties is a REIT focused on outpatient medical buildings, laboratories, and retirement communities, offering a 6.9% dividend yield [8] - The company faced challenges due to decreased demand for lab space from biotech start-ups but has merged with Physician's Realty to enhance its portfolio [9] - In Q2, adjusted funds from operations (FFO) rose to $0.44 per share, supporting current dividend payments of $0.305 per share per quarter [10] Group 3: Ares Capital - Ares Capital is a business development company (BDC) that provides loans to businesses, reporting a 10.9% average yield on its debt securities [11] - The stock offers an 8.4% yield, with a stable quarterly payout since 2009, despite some variability in past extra dividend payments [12] - Ares Capital is externally managed by Ares Management, which has approximately $546 billion in assets under management, and has a low non-accrual loan rate of 1.2% [13][14]
Altria Q2 Earnings Beat Estimates, FY25 EPS Guidance Narrowed
ZACKS· 2025-07-30 18:50
Core Insights - Altria Group Inc. reported second-quarter 2025 results with both revenue and earnings exceeding expectations and showing year-over-year growth [1][2][11] Financial Performance - Adjusted earnings per share (EPS) for the second quarter were $1.44, an increase of 8.3% year over year, surpassing the Zacks Consensus Estimate of $1.37 [2][11] - Net revenues totaled $6,102 million, a decline of 1.7% year over year, primarily due to decreased revenues in the smokeable products segment, partially offset by growth in oral tobacco products [3][11] - Revenues net of excise taxes increased by 0.2% to $5,290 million, beating the consensus estimate of $5,190 million [3] Segment Performance - **Smokeable Products**: Net revenues fell 2.5% year over year to $5,357 million, driven by reduced shipment volumes, although higher pricing provided some offset [4][5] - Domestic cigarette shipment volumes decreased by 10.2%, attributed to industry decline and retail share losses, while cigar shipment volumes increased by 3.7% [5] - Adjusted operating companies' income (OCI) in this segment rose 4.2% to $2,947 million, with adjusted OCI margins growing by 2.9 percentage points to 64.5% [6] - **Oral Tobacco Products**: Net revenues increased by 5.9% to $753 million, mainly due to higher pricing, despite a decline in domestic shipment volumes by 1% [7][8] - Adjusted OCI in this segment grew by 10.9%, with adjusted OCI margins increasing by 3.1 percentage points to 68.7% [8] Shareholder Returns and Guidance - The company repurchased 4.7 million shares for $274 million in the second quarter, with $400 million remaining under its $1 billion share repurchase program [10] - Altria paid dividends totaling $1.7 billion in the second quarter [10] - The company narrowed its full-year 2025 adjusted EPS guidance to a range of $5.35 to $5.45, indicating a year-over-year growth of 3% to 5% [11][12]